Immunai raises $215M in a Series B funding round
Main Highlights: On Wednesday, Immunai announced a $215 million Series B capital round. According to Noam Solomon, Immunai's CEO and ...
Main Highlights: On Wednesday, Immunai announced a $215 million Series B capital round. According to Noam Solomon, Immunai's CEO and ...
Main Highlights immunitoAI, a biotech startup creating an AI-powered antibody discovery and screening platform, revealed that it had secured $1 ...
Introduction Longenesis, a Riga-based firm, has raised €1 million in a late seed round led by Rustam Gilfanov. Ilya Suharenko, ...
In the dynamic and ever-evolving landscape of sports entertainment, Apple...
Read moreDetailsAppedus is a mobile app ecosystem focused news publishing platform which covers various topics like app design, app development, app marketing and other relevant news, views or opinions. We also publish industry insights, e-books, developer interviews and e-magazines. You can get in touch with us on hola@appedus.com or you can snail mail us at
Medianiti Ltd. Brooklands Business Park, Wellington Way, Weybridge KT13 0TT, United Kingdom
© 2025 Appedus - Appedus All Right Reserved
© 2025 Appedus - Appedus All Right Reserved